Towards novel processes for the fine-che
โ
Gjalt W Huisman; David Gray
๐
Article
๐
2002
๐
Elsevier Science
๐
English
โ 117 KB
In response to the need in the pharmaceutical industry for more complex, chiral molecules, fine-chemical companies are embracing new manufacturing technologies to produce compounds of these specifications. In particular, recent developments in biocatalysis combined with novel process engineering are